SCHEMBL2935759

SCHEMBL2935759

O=S1(=O)NCCN1c1cc2cc(-c3cccc(C(F)(F)F)c3)ccc2cc1O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGR P06401 1/20 0.39
PARP10 Q53GL7 1/20 0.37
PARP11 Q9NR21 1/20 0.37
PTPN1 P18031 1/20 0.37
ASIC3 Q9UHC3 1/20 0.37
MAPT P10636 1/20 0.36
PLG P00747 2/20 0.36
PLAU P00749 2/20 0.36
PLAT P00750 2/20 0.36
JAK2 O60674 1/20 0.36
CA12 O43570 1/20 0.35
CA9 Q16790 1/20 0.35
SLC6A7 Q99884 1/20 0.35
KIF11 P52732 1/20 0.35
S1PR5 Q9H228 1/20 0.35
GAA P10253 1/20 0.35
MGLL Q99685 1/20 0.35
GHSR Q92847 1/20 0.35
PARP1 P09874 1/20 0.34
HRH3 Q9Y5N1 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4556988 0.86 FFAR1 (0.40) PTPN1SLC6A7MGLLGHSRHRH3
SCHEMBL630189 0.82 PTPN1 (0.58) PGRPARP10PARP11PTPN1MAPT
SCHEMBL2933403 0.81 PTPN1 (0.39) PTPN1MAPT
SCHEMBL2929513 0.79 PTPN1 (0.41) PTPN1GHSR
SCHEMBL629600 0.69 PTPN1 (0.59) PTPN1SLC6A7MGLLGHSRHRH3
SCHEMBL630508 0.67 PTPN1 (0.66) PTPN1
SCHEMBL629950 0.67 PTPN1 (0.59) PTPN1MGLL
SCHEMBL4784078 0.66 PTPN1 (0.39) PTPN1
SCHEMBL4557317 0.66 PTPN1 (0.39) PTPN1
SCHEMBL629611 0.66 PTPN1 (0.58) PGRPTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2227245-A2 COMBINATION OF PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND HUMAN GROWTH HORMONE FOR THE TREATMENT OF MUSCLE ATROPHY AND RELATED DISORDERS Novartis AG (CH) 2010-09-15 EP disclosed
WO-2009068689-A2 COMBINATION OF PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND HUMAN GROWTH HORMONE FOR THE TREATMENT OF MUSCLE ATROPHY AND RELATED DISORDERS NOVARTIS AG (CH) 2009-06-04 WO disclosed